Caballa Susan 4
4 · ALIMERA SCIENCES INC · Filed Dec 21, 2012
Insider Transaction Report
Form 4
Caballa Susan
SEE REMARKS
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-12-19+90,000→ 90,000 totalExercise: $1.66Exp: 2022-12-18→ Common Stock (90,000 underlying) - Award
Employee Stock Option (Right to Buy)
2012-12-19+35,000→ 35,000 totalExercise: $1.66Exp: 2022-12-18→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]This option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period.
- [F2]This option shall become exercisable if and only if on or before June 30, 2013 the United Kingdom's National Institute for Health and Clinical Excellence recommends ILUVIEN(R) for the treatment of diabetic macular edema, in which case this option shall vest in forty-eight equal monthly installments beginning on January 19, 2013, provided Reporting Person remains continuously employed by the Issuer through each vesting period.